Genus (LON:GNS) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says

Genus (LON:GNS) had its target price hoisted by analysts at Deutsche Bank Aktiengesellschaft from GBX 2,250 ($30.19) to GBX 2,550 ($34.22) in a research note issued to investors on Tuesday, Marketbeat reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of 6.92% from the company’s previous close.

Separately, Shore Capital restated a “buy” rating and set a GBX 2,750 ($36.90) price target on shares of Genus in a report on Tuesday.

Genus Stock Down 1.0%

Genus stock opened at GBX 2,385 ($32.00) on Tuesday. Genus has a fifty-two week low of GBX 1,424 ($19.11) and a fifty-two week high of GBX 2,485 ($33.35). The stock has a market cap of £1.56 billion, a PE ratio of 197.70, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The firm’s 50-day simple moving average is GBX 2,057.23 and its 200 day simple moving average is GBX 1,870.08. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.